Zhejiang Beta Pharma's Series A Round

Zhejiang Beta Pharma raised a round of funding on June 11, 2010. Investors include Lilly Asia Ventures.

Beta Pharma is a Chinese biotech company focused on the development of therapies for cancer and inflammatory diseases. In 2011, the company received Chinese FDA approval for its "Class One" new drug I…

Articles about Zhejiang Beta Pharma's Series A Round: